SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-19-000150
Filing Date
2019-11-05
Accepted
2019-11-05 16:04:58
Documents
1
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157298788254421.html 4  
1 FORM 4 wf-form4_157298788254421.xml 4 5650
  Complete submission text file 0000920465-19-000150.txt   6892
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
MULROY DENNIS (Reporting) CIK: 0001276840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 191193257